Patent Portfolio

• As of 9/30/03: 73 U.S. patents and 60 U.S. pending
• Comparable international protection
• MIT’s Technology Review Patent Scorecard 20031 ranked the power of Emisphere’s intellectual property in the top 10% among the world’s leading pharmaceutical companies

1 As ranked by Technology Review and CHI Research, Inc. (published in Financial Times 5/20/03)

Previous slide

Next slide

Back to first slide

View graphic version